Preclinical studies have provided evidence of the advantageous effects of interleukin-10 (IL-10) and transforming growth factor-beta (TGF-beta) in enhancing cardiac function and diminishing fibrosis in experimental models of heart failure [32]. Here, IL10 is linked to heart failure.